Flexible approaches in the design of subcutaneous immunotherapy protocols for Hymenoptera venom allergy

Annals of Allergy, Asthma and Immunology

Volumn 97, Issue 1, 2006, Pages 92-97

  Alessandrini, Arnaldo E ^a   Berra, Daniele ^b   Rizzini, Fabio Lodi ^c   Mauro, Marina ^d   Melchiorre, Antonietta ^e   Rossi, Francesco ^f   Spezia, Daniele ^f   Stanizzi, Rosario ^g   Ricciardi, Luisa ^h   Burastero, Samuele E ⁱ  

^a General Medicine Unit   (Italy)

^b Circolo Hospital   (Italy)

^c Department of Paediatrics   (Italy)

^d SANT ANNA HOSPITAL   (Italy)

^e Desenzano Hospital   (Italy)

^f Ospedale Predabissi   (Italy)

^g A MANZONI HOSPITAL   (Italy)

^h UNIVERSITY OF MESSINA   (Italy)

ⁱ SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ALUTARD SQ; AQUAGEN SQ; CORTICOSTEROID; HYMENOPTERA VENOM; WASP VENOM;

ALLERGY; ARTICLE; CONTROLLED STUDY; DRUG TOLERABILITY; HUMAN; IMMUNIZATION; IMMUNOTHERAPY; INJECTION SITE EDEMA; INJECTION SITE ERYTHEMA; INSECT STING; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PRIORITY JOURNAL; WASP;

EID: 33746624280     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)61376-2     Document Type: Article

References (24)

1. Charpin D, Birnbaum J, Vervloet D. Epidemiology of hymenoptera allergy. Clin Exp Allergy. 1994;24:1010-1015.
2. Valentine MD. Allergy to stinging insects. Ann Allergy. 1993;70:427-432.
3. Muller U, Thurnheer U, Patrizzi R, et al. Immunotherapy in bee sting hypersensitivity: bee venom versus wholebody extract. Allergy. 1979;34:369-378.
4. Hunt KJ, Valentine MD, Sobotka AK, et al. A controlled trial of immunotherapy in insect hypersensitivity. N Engl J Med. 1978;299:157-161.
5. Muller UR, Golden DB, Demarco PJ, et al. Immunotherapy for hymenoptera venom and biting insect hypersensitivity. Clin Allergy Immunol. 2004;18:541-559.
6. Wyss M, Scheitlin T, Stadler BM, et al. Immunotherapy with aluminum hydroxide adsorbed insect venom extracts (Alutard SQ): immunologic and clinical results of a prospective study over 3 years. Allergy. 1993;48:81-86.
7. Mosbech H, Mailing HJ, Biering I, et al. Immunotherapy with yellow jacket venom: a comparative study including three different extracts, one adsorbed to aluminium hydroxide and two unmodified. Allergy. 1986;41:95-103.
8. Quercia O, Rafanelli S, Puccinelli P, et al. The safety of cluster immunotherapy with aluminium hydroxide-adsorbed honey bee venom extract. J Investig Allergol Clin Immunol. 2001;11:27-33.
9. Carriere C, Dell'Andrea M, Jocher C, et al. Specific immunotherapy with purified venoms of Apis mellifera and Vespula spp adsorbed to A1-hydroxide: a ten-year clinical experience in 4 centers in Trentino-South Tyrol. Ital J Allergy Clin Immunol. 1999;9:241-248.
10. Brehler R, Wolf H, Kutting B, et al. Safety of a two-day ultrarush insect venom immunotherapy protocol in comparison with protocols of longer duration and involving a larger number of injections. J Allergy Clin Immunol. 2000;105:1231-1235.
11. Elsner J, Sack A, Petering H, et al. Ultrarush SIT in venom allergy. Allergy. 2000;55:582-583.
12. Malling HJ, Djurup R, Sondergaard I, et al. Clustered immunotherapy with Yellow Jacket venom: evaluation of the influence of time interval on in vivo and in vitro parameters. Allergy. 1985;40:373-383.
13. Cadario G, Marengo F, Ranghino E, et al. Higher frequency of early local side effects with aqueous versus depot immunotherapy for Hymenoptera venom allergy. J Investig Allergol Clin Immunol. 2004;14:127-133.
14. Miller AC, Tees EC. A metabolizable adjuvant: clinical trial of grass pollen-tyrosine adsorbate. Clin Allergy. 1974;4:49-55.
15. Stull A, Cook RA, Sherman WB. Experimental and clinical studies of fresh and modified pollen extracts. J Allergy. 1940;11:439.
16. Lockey RF, Turkeltaub PC, Olive ES, et al. The Hymenoptera venom study, III: safety of venom immunotherapy. J Allergy Clin Immunol. 1990;86:775-780.
17. Mueller HL. Diagnosis and treatment of insect sensitivity. J Asthma Res. 1966;3:331-333.
18. Wuthrich B. Classification of sting insect sensitivity. J Investig Allergol Clin Immunol. 2001;11:132.
19. Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med. 1998;17:857-872.
20. Antonicelli L, Bilo MB, Bonifazi F. Epidemiology of Hymenoptera allergy. Curr Opin Allergy Clin Immunol. 2002;2:341-346.
21. European Academy of Allergology and Clinical Immunology. Position paper: immunotherapy with Hymenoptera venoms. Allergy. 1993;48(suppl):36-46.
22. Bousquet J, Fontez A, Aznar R, et al. Combination of passive and active immunization in honeybee venom immunotherapy. J Allergy Clin Immunol. 1987;79:947-954.
23. Muller U, Hari Y, Berchtold E. Premedication with antihistamines may enhance efficacy of specific-allergen immunotherapy. J Allergy Clin Immunol. 2001;107:81-86.
24. Tankersley MS, Walker RL, Butler WK, et al. Safety and efficacy of an imported fire ant rush immunotherapy protocol with and without prophylactic treatment. J Allergy Clin Immunol. 2002;109:556-562.